Country

Clinical trials in Turkey (Türkiye)

Active obesity and GLP-1 studies with at least one location in Turkey (Türkiye).

78active studies
26recruiting now
11countries represented
40largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowNot applicable

Executive Function in Obese

ObesityCondition
Intervention not listedTreatment
Turkey (Türkiye)1 locations
Kutahya Health Sciences UniversitySponsor
Updated 2026-03-10 · NCT06578091See eligibility →
Recruiting nowNot applicable

Vestibular Function in Obesity

Obesity, Vestibular Function DisorderCondition
Intervention not listedTreatment
Turkey (Türkiye)1 locations
Istanbul Aydın UniversitySponsor
Updated 2025-06-24 · NCT07033221See eligibility →
Opening soonNot applicable

Diet and WB-EMS Effects in Obesity

Obesity & Overweight, Metabolic DisordersCondition
Energy-Restricted Diet, Whole-Body Electromyostimulation (WB-EMS)Treatment
Turkey (Türkiye)2 locations
Firat UniversitySponsor
Updated 2026-05-14 · NCT07562724See eligibility →
Obesity, Coronary Artery DiseaseCondition
aerobic exercise on the treadmill+For both groups, patients will be recommended joint range of motion (ROM), stretching, strengthening, posture and balance and flexibility exercises for all joints., Walking at an intensity of 12-13 RPE+For both groups, patients will be recommended ROM, stretching, strengthening, posture and balance and flexibility exercises for all joints.Treatment
Turkey (Türkiye)1 locations
Kayseri City HospitalSponsor
Updated 2024-09-19 · NCT06318741See eligibility →
This page shows the first 60 studies. Use the full search to filter all matches.

Related countries

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.